Plasma immunoreactive leptin concentration in end-stage renal disease

Clinical Science

Volumn 93, Issue 2, 1997, Pages 119-126

  Howard, Jane K ^a   Lord, Graham M ^a   Clutterbuck, Elaine J ^a   Ghatei, Mohammad A ^a   Pusey, Charles D ^a   Bloom, Stephen R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Anorexia; Chromatography; Continuous ambulatory peritoneal dialysis; End stage renal failure; Haemodialysis; Immunoreactive leptin; Malnutrition; Renal transplant

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CREATININE; LEPTIN; PREDNISOLONE;

ADULT; ANOREXIA; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEMODIALYSIS; HORMONE BLOOD LEVEL; HUMAN; IMMUNOREACTIVITY; KIDNEY CLEARANCE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SEX DIFFERENCE; STEROID THERAPY;

EID: 0030801102     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0930119     Document Type: Article

References (37)

1. Blumenkrantz MJ. Nutrition. In Daugirdas JT, Ing TS, eds. Handbook of dialysis. Boston: Little, Brown and Company, 1994; 374-400.
2. Acchiardo S, Moore L, Latour P. Malnutrition as the main factor in morbidity and mortality of haemodialysis patients. Kidney Int 1983; 24: S199-203.
3. Gutman R, Blumenkrantz M, Chan Y-K, et al. Controlled comparison of haemodialysis and peritoneal dialysis: Veterans Administration multicenter study. Kidney Int 1984; 26: 459-70.
4. Marckmann P. Nutritional status and mortality of patients in regular dialysis therapy. J Int Med 1989; 226: 429-32.
5. Harvey K, Blumenkrantz M, Levine S, Blackburn G. Nutritional assessment and treatment of chronic renal failure. Am J Clin Nutr 1980; 33: 1586-97.
6. Coles G. Body composition in chronic renal failure. Q J Med 1972; 41: 25-47.
7. Maack T, Johnson V, Kau S, Figueiredo J, Sigulem D. Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int 1979; 16: 251-70.
8. Katz A, Emmanouel D. Metabolism of polypeptide hormones by the normal kidney and in uremia. Nephron 1978; 22: 69-80.
9. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Freidman J. Positional cloning of the mouse obese gene and its human homologue. Nature (London) 1994; 372: 425-32.
10. Halaas J, Gajiwala K, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-6.
11. Caro J, Sinha M, Kolaczynski J, Zhang P, Considine R. Leptin: the tale of an obesity gene. Diabetes 1996; 45: 1455-62.
12. Maffei M, Halaas J, Ravussin R. Leptin levels in human and rodent: measurement of plasma leptin and ob mRNA in obese and weight-reduced subjects. Nat Med 1995; 1: 1155-61.
13. Considine R, Sinha M, Heinman M, et al. Serum immunoreactive leptin in normal weight and obese humans. N Engl J Med 1996; 334: 292-5.
14. Boden G, Chen X, Mozzoli M, Ryan I. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 1996; 81: 3419-23.
15. Cumin F, Baum H-P, Levens N. Leptin is cleared from the circulation primarily by the kidney. Int J Obesity 1996; 20: 1120-6.
16. Taylor IL, Sells RA, McConnell RB, Dockray GJ. Serum gastrin in patients with chronic renal failure. Gut 1980; 21: 1062-7.
17. Ma Z, Gingerich R, Santiago J, Klein S, Smith C, Landt M. Radioimmunoassay of leptin in human plasma. Clin Chem 1996; 42: 942-6.
18. Weatherburn MW, Trotman RB, Jackson SH. Specific method for serum creatinine determination based on ion-exchange chromatography and an automated alkaline picrate reaction: a proposed reference method. Clin Biochem 1978; 11: 159-66.
19. Laurent TC, Killander JA. A theory of gel filtration and its experimental verifications. J Chromatogr 1964; 14: 317-30.
20. Lam H-C, Takahashi K, Ghatei MA, Bloom SR. Presence of immunoreactive endothelin in human milk. FEBS Lett 1990; 261: 184-6.
21. Rosenbaum M, Nicholson M, Hirsch J, Heymsfield S, Gallagher D, Chu F, Leibel R. Effects of gender, body composition, and the menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996; 81: 3424-7.
22. Ostlund R, Yang J, Klein S, Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 1996; 81: 3909-13.
23. Grinspoon S, Gulick T, Askari H et al. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab 1996; 81: 3861-3.
24. Hickey MS, Israel RG, Gardiner SN, et al. Gender differences in serum leptin levels in humans. Biochem Mol Med 1996; 59: 1-6.
25. Bommer J. Sexual dysfunction in chronic renal failure. In: Cameron S, Davison AM, Grunfeld J-P, Kerr D, Ritz E, eds. Oxford Textbook of Clinical Nephrology. Oxford: Oxford Medical Publications, 1992: 1329-1343.
26. Kurtin PS, Shapiro AC, Tomita H, Raizman D. Volume status and body composition of chronic dialysis patients: utility of bioelectric impedence plesmography. Am J Nephrol 1990; 10: 363-7.
27. Murakami T, Mitsuru I, Shima K. Dexamethasone regulates obese gene expression in isolated rat adipocytes. Biochem Biophys Res Commun 1995; 214: 1260-7.
28. Vos P-D, Saladin R, Auwerx J, Staels B. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. 1995; 270: 15958-61.
29. Larsson H, Ahren B. Short term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women. J Clin Endocrinol Metab 1996; 81: 4428-32.
30. Grunfeld C, Zhao C, Fuller J, Pollock A, Moser A, Friedman J, Feingold KR. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 1996; 97: 2152-7.
31. Bennett Bd, Solar GP, Yuan JQ, Mathias J, Thomas GR, Matthew W. A role for leptin and its cognate receptor in haematopoiesis. Curr Biol 1996; 6: 1170-80.
32. Olbricht CJ, Frei U, Koch KM. Haemodialysis, complications of haemodialysis, and adequacy of haemodialysis. In: Cameron S, Davison AM, Grunfeld J-P, Kerr D, Ritz E, eds. Oxford Textbook of Clinical Nephrology. Oxford: Oxford Medical Publications, 1992: 1420-1.
33. Lindsay RM, Spanner E, Heidenheim AP, Lindsay S, LeFebvre JM. The influence of dialysis membrane upon protein catabolic rate. ASAIO Trans 1991; 37: M134-5
34. Sinha MK, Opentanova I, Ohannesian J. Evidence of free and bound leptin in the human circulation. J Clin Invest 1996; 98: 1277-82.
35. Houseknecht K, Mantzoros CS, Kuliawat R, Hadro E, Flier JS, Kahn BB. Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes 1996; 45: 1638-43.
36. Reidenbeg MM. The binding of drugs to plasma proteins from patients with poor renal function. In: Gibaldi M, Prescott L, eds. Handbook of Clinical Pharmacokinetics. Balgowlah: ADIS Health Science Press, 1983; Section III, 89-95.
37. Schwartz M, Peskind E, Raskind M, Boyko E, Porte D. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 1996; 2: 589-93.